Board Member @ Luqa Pharmaceuticals (June 2018 - February 2021)
Board Member @ (June 2018 - January 2021)
Board Observer @ (May 2017 - January 2024)
Principal @ (January 2017 - December 2021)
Board Observer @ (June 2016 - August 2025)
Board Member @ Curatia Medical (November 2015 - September 2025)
Vice President @ (December 2014 - December 2016)
Senior Associate, Investment Banking @ (December 2010 - December 2014)
Analyst, Investment Banking @ (July 2008 - December 2010)
Intern @ (April 2007 - June 2008)
Tim Xiao Education
The Johns Hopkins University
Master of Science - MS (Biotechnology)
2021-2024
Shanghai Jiao Tong University
B.Sc. (International Economics & Trade)
2004-2008
The University of British Columbia
Exchange (International Business)
2006-2007
Tim Xiao Skills
Corporate Finance
Finance
Investments
Private Equity
Venture Capital
Valuation
Strategy
Financial Modeling
Equities
Mergers & Acquisitions
Investment Advisory
Capital Markets
Market Analysis
Process Management
Business Strategy
Financial Analysis
Investment Banking
IPO
Mergers
Due Diligence
Mergers & Acquisitions
Emerging Markets
International Business
Strategic Planning
Greater China
Mergers and Acquisitions
PE
Visual C++
Tim Xiao Summary
Tim Xiao, based in Hong Kong, is currently a Chief Financial Officer at Eccogene. Tim Xiao brings experience from previous roles at Sirius Therapeutics, ReNiva Inc., Zenas BioPharma and Rgenta Therapeutics Inc.. Tim Xiao holds a 2021 - 2024 Master of Science - MS in Biotechnology @ The Johns Hopkins University. With a robust skill set that includes Corporate Finance, Finance, Investments, Private Equity, Venture Capital and more. Tim Xiao has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Tim Xiao?
Find contact details for 700 million professionals.